Nazy Zomorodian
Urology · Los Angeles, CANPI 1770502403
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $194,833 of the $309,326 with a category attached, or 63.0%. 14 manufacturers reported payments, led by Johnson & Johnson at 31.5% of the total. 2025 is the largest year on record at $129,572, 4.8 times the $26,825 reported in 2021. Among urology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 547 payments — averaging $565.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$97K
- Astellas Pharma US Inc$66K
- AstraZeneca$38K
- Seagen Inc.$37K
- Pfizer$31K
- Sumitomo Pharma America, Inc.$16K
- plus $24K from 8 others
Across 2 payments — averaging $1990.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$4K
What the payments were for
- Consulting fees$21,6557%
- Speaking & faculty fees$194,83363%
- Travel & lodging$75,79925%
- Food & beverage$16,9555%
- Education$850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 160 | $97,366 |
| Astellas Pharma US Inc | 115 | $66,237 |
| AstraZeneca | 71 | $37,732 |
| Seagen Inc. | 73 | $36,775 |
| Pfizer | 53 | $31,365 |
| Sumitomo Pharma America, Inc. | 31 | $16,262 |
| Urogen Pharma, Inc. | 18 | $14,736 |
| Janssen Scientific Affairs, LLC | 13 | $7,370 |
| Merck | 2 | $675 |
| AVEO Pharmaceuticals, Inc. | 4 | $531 |
| Astellas Pharma Inc | 1 | $141 |
| Gilead | 3 | $61 |
| Boston Scientific | 2 | $56 |
| Dendreon Pharmaceuticals LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$309,326 in reported general payments places this provider in the 95th percentile of 1,324 urology providers in California.
Other urology in Los Angeles
- Arie BelldegrunLos Angeles$1.8M
- Mihir DesaiLos Angeles$1.5M
- Stuart HoldenLos Angeles$1.1M
- William AronsonLos Angeles$540K
- Amir LebastchiLos Angeles$478K
- Jeffrey Loh-DoyleLos Angeles$308K
- Siamak DaneshmandLos Angeles$306K
- Karim ChamieLos Angeles$291K
- Brian ShuchLos Angeles$166K
- Robert ReiterLos Angeles$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.